FOR IMMEDIATE RELEASE: 1 November 2022
Nearly 70% of Life-Sci hiring is in the last quarter of the year
Biotech Search in 6-8 weeks means you can secure talent by end 2022
• From our sector experience the majority of recruitment is done in the last quarter
• Our specialist bespoke talent search solves the annual rush to make offers (and get acceptances) by December
• We do the heavy lifting in our Biotech Search package to get you where you need to be in 6-8 weeks
Singular Talent’s Biotech Search service is a bespoke service suited to meet the hiring needs of early-stage Biotechs to secure…
PhoreMost enters multi-target collaboration with targeted protein degradation leader Arvinas
PhoreMost to deploy its SITESEEKER® Targeted Protein Degradation platform to enable drug discovery against multiple therapeutic targets
Cambridge, UK, 28 October 2022: PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has entered into a multi-target collaboration with Arvinas, an industry leader in targeted protein degradation (TPD). Under the terms of the agreement, PhoreMost will receive research funding…
MD-T is proud sponsor of Fierce European TMF Summit. This is an excellent opportunity for organisations to share tools, strategies and methodologies to help over come dynamic TMF challenges.
Come meet the MD-T team at our booth and discuss the concerns your organisation may be facing to comply and implement the GDPR, UK Data Protection Act or any other international data protection regulation.
Mr. Damien Mair, chief development officer(CDO) at MDT, is also part of panel discussion below. Where he will highlight the updates and challenges with the compliance of GDPR and UK Data Protection…
Check out this month's People Pathways newsletter for your monthly round-up of employee engagement activities.
AMSBIO has added a new range of Vesicular Stomatitis Virus (VSV) to its suite of virus-based tools for cell engineering and the study of viral infection.
Vesicular Stomatitis Virus is an enveloped, negative-stranded RNA virus with a simple structure. Its ability to infect a wide range of mammalian cell types has made it a valuable tool to study virus entry, replication, and assembly. A key advantage of the AMSBIO VSV model is that it undergoes only one round of replication. Consequently, it is safe to use and requires only a biosafety level 2 facility.
VSV vectors offer a robust model of…
ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has announced the formation of a new subsidiary company, Cytolytix Limited, which has signed an IP license agreement with Kings College London to progress the preclinical development of its triple negative breast cancer treatment, CLX001.
Triple negative breast cancer accounts for around 15% of breast cancers. It is usually more aggressive, harder to treat, and more likely to recur than many other cancers.
CLX001 is a peptide in a nanoparticle formulation, developed for the treatment of…
Asahi Kasei Pharma has announced the new application period for their annual “Open Innovation” solicitation of proposals for drug discovery research. Through collaboration with universities, research institutes, and companies around the world, Asahi Kasei Pharma has been supporting innovation in drug discovery since 2018 and will fund up to $200,000 US per year for each selected proposal of the upcoming round in 2023.
With “Global Specialty Pharma” highlighted as one of the 10 Growth Gears in our 2024 Medium-term Management Plan, endeavors like this for discovering new drugs for conditions…
Apply to Win a Chance to Accelerate Your Innovation with Takeda UK!
Takeda UK, in partnership with The ADHD Foundation and Eastern AHSN (Academic Health Science Network), is launching a call for applications to our newest digital challenge to benefit patients who have Attention Deficit Hyperactivity Disorder (ADHD). What can Takeda offer?
A dedicated point of contact at Takeda UK
Finalists will receive a direct response about collaboration potential at the end of the Innovation Challenge Takeda’s resources & expertise
Partnership with Takeda UK including…
Life science specialists – AMSBIO offer an extensive range of highly characterized, high purity exosomes for use as control standards in applications including marker assessment, immunocapture performance evaluation, exosome quantification, OMICS analysis, flow cytometry and electron microscopy.
Exosomes or extracellular vesicles (EV) are small endosome derived lipid nanoparticles (50-300nm in diameter), actively secreted by exocytosis in most living cells. Exosomes have been shown to have pleiotropic physiological and pathological functions and play significant roles in diverse conditions…